ArticleJournal of asthma and allergy2026
Asthma in Individuals Over 60 Years: A Comparative Analysis Across Age Subgroups.
Article in Journal of asthma and allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Asthma is often not adequately treated in individuals over 60 years of age due to atypical symptom presentation, comorbidities that overlap with asthma symptoms, and difficulties with diagnostic testing. The aim of this study was to evaluate asthma control, its phenotypes, accompanying comorbidities and quality of life, as well as treatment patterns, in patients aged 60 years and older. The assessment also covered asthma treatment and control in specific age subgroups. Patients and Methods: A multicenter, cross sectional study of 345 asthma patients over 60 years of age and 410 matched controls without obstructive lung disease was conducted. Spirometry, Forced Oscillation Technique (FOT) assessment, bronchodilator reversibility test, and patient-reported outcome data, including Asthma Control Test (ACT), Asthma Quality of Life Questionnaire (AQLQ), and 36-Item Short Form Survey (SF-36) data were analyzed. Results: Severe asthma was present in 25% (n=87) of the study population. A total of 48% (n= 165) of all asthma patients presented the T2 phenotype. The FOT proved useful where spirometry was limited. The asthma patients had significantly higher rates of depression (p=0.02), cognitive decline (p=0.02), and multimorbidity (p=0.01) than the non-asthma patients did. The quality-of-life score (AQLQ) was consistently lower in the asthma group: 3.78 ± 0.91 (median ± interquartile range) vs 4.29 ± 1.81 in non-asthma group (p=0.01). In the analysis of subgroups, older patients over 80 years had significantly poorer asthma control, and reduced quality of life in SF-36 questionnaire (55.521 score in younger vs 46.991 in older, for p=0.01). Conclusion: Asthma in older age is often associated with other comorbidities, which can have a significant impact on a person's quality of life and general health. Patients are often undertreated, which results in poorer asthma control, particularly among the oldest patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.